BioSpace News Archive

Capricor Therapeutics today announced commencement of dosing in HOPE-3, a Phase 3 clinical trial investigating CAP-1002.

Kowa Pharmaceuticals America,Inc. Announces Publication of Phase 3 Data Supporting FDA Approval of SEGLENTIS ® (celecoxib 56-mg and tramadol hydrochloride 44mg)CI-V as an Efficacious Alternative for Moderate-to-Severe Acute Pain in Appropriate Patients.

Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company, announced today that Martin Brown Jr. has joined the company’s Board of Directors.

Gb Sciences is a plant-inspired, biopharmaceutical research and drug development company that began building its proprietary digital research and analytics platform long before the pandemic sparked a digital transformation.

Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) (“Allena” or the “Company”), a biopharmaceutical company deploying its novel oral biologic platform to discover, develop and commercialize first-in-class, oral enzyme therapeutics for difficult-to treat metabolic diseases, today reported completion of enrollment of the first two cohorts of its ALLN-346 Phase 2a Study 202 in gout patients with stage 2 (cohort A) and stage 3 (cohort B) chronic kidney disease (CKD).

INOVIO announced that it has implemented a corporate reorganization designed to extend its cash runway and to focus on key clinical programs with the goal to drive long-term growth.

Journey Colab, a biopharmaceutical company unlocking the science of psychedelics to build a new model of addiction care, today announced the appointment of Joel A. Posener, MD as Chief Medical Officer.

Dr. Daniel Alexander , MD joins a growing Auburn Orthopedic Specialists Practice (AOS) that is affiliated with Auburn Community Hospital.

Establishment Labs Holdings Inc. today announced publication of its 2021 Sustainability Review to coincide with the fourth anniversary of the company’s public listing on NASDAQ.

Milestone Scientific Inc. (NYSE:MLSS) , a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced it has entered into a distribution agreement granting Hager & Werken exclusive distribution rights to market Milestone’s STA Single Tooth Anesthesia System ® (STA) in Germany and Austria.